These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3323537)

  • 1. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
    Parratt JR; Coker SJ; Wainwright CL
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.
    Parratt JR; Coker SJ
    J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S65-70. PubMed ID: 2410739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ
    J Mol Cell Cardiol; 1984 Jul; 16(7):633-41. PubMed ID: 6433026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.
    Burke SE; Antonaccio MJ; Lefer AM
    Basic Res Cardiol; 1982; 77(4):411-22. PubMed ID: 6890805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart.
    Sakai K; Ito K; Ogawa K
    J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    J Mol Cell Cardiol; 1984 Jan; 16(1):43-52. PubMed ID: 6366241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis.
    Ridley PD; Yacoub MH; Curtis MJ
    Cardiovasc Res; 1992 Apr; 26(4):309-15. PubMed ID: 1638559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonate metabolism in myocardial ischemia and reperfusion.
    Tada M; Kuzuya T; Hoshida S; Nishida M
    J Mol Cell Cardiol; 1988 Mar; 20 Suppl 2():135-43. PubMed ID: 3137347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs.
    Coker SJ; Ledingham IM; Parratt JR; Zeitlin IJ
    Br J Pharmacol; 1981 Apr; 72(4):593-5. PubMed ID: 7284679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
    Tanabe M; Terashita Z; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias?
    Podzuweit T; Binz KH; Nennstiel P; Flaig W
    Cardiovasc Res; 1989 Feb; 23(2):81-90. PubMed ID: 2550132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
    Pieper GM; Farber NE; Gross GJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):13-22. PubMed ID: 3054935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1985 Sep; 86(1):259-64. PubMed ID: 3840397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
    O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
    Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia-reperfusion arrhythmias and lipids: effect of human high- and low-density lipoproteins on reperfusion arrhythmias.
    Mochizuki S; Okumura M; Tanaka F; Sato T; Kagami A; Tada N; Nagano M
    Cardiovasc Drugs Ther; 1991 Mar; 5 Suppl 2():269-76. PubMed ID: 1906736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.